دورية أكاديمية

Use of remdesivir for COVID-19 pneumonia in patients with advanced kidney disease: A retrospective multicenter study

التفاصيل البيبلوغرافية
العنوان: Use of remdesivir for COVID-19 pneumonia in patients with advanced kidney disease: A retrospective multicenter study
المؤلفون: F. Stancampiano, N. Jhawar, W. Alsafi, J. Valery, D.M. Harris, P. Kempaiah, S. Shah, M.G. Heckman, H. Siddiqui, C.R. Libertin
المصدر: Clinical Infection in Practice, Vol 16, Iss , Pp 100207- (2022)
بيانات النشر: Elsevier, 2022.
سنة النشر: 2022
المجموعة: LCC:Infectious and parasitic diseases
مصطلحات موضوعية: Infectious and parasitic diseases, RC109-216
الوصف: Background and objectives: Remdesivir, an antiviral drug routinely used in the treatment of COVID-19 has not yet received FDA approval for use in patients with advanced kidney disease defined as GFR
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2590-1702
Relation: http://www.sciencedirect.com/science/article/pii/S2590170222000759; https://doaj.org/toc/2590-1702
DOI: 10.1016/j.clinpr.2022.100207
URL الوصول: https://doaj.org/article/b3306d34aef2460d93b8c071bb8f493d
رقم الأكسشن: edsdoj.b3306d34aef2460d93b8c071bb8f493d
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:25901702
DOI:10.1016/j.clinpr.2022.100207